Summary of Study ST001362

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000932. The data can be accessed directly via it's Project DOI: 10.21228/M8710D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001362
Study TitleCalifornia mouse fecal metabolite analysis
Study TypeEffect of BPA and genistein exposure on the fecal metabolome
Study SummaryXenoestrogens are found in plant products, such as genistein (GEN), or industrial chemicals, such as bisphenol A (BPA), present in consumer products that are also pervasive in the environment. Early exposure to such endocrine disrupting chemicals (EDC) may affect neural development by inducing direct neural effects and/or through the microbiome-gut-brain axis. To test this hypothesis, California mice (Peromyscus californicus) offspring were exposed through the maternal diet to GEN (250 mg/kg feed weight) or BPA (5 mg/kg feed weight, low dose- LD and 50 mg/kg, upper dose-UD), and dams were placed on these diets two weeks prior to breeding, throughout gestation, and lactation. Various behaviors, gut microbiome, and fecal metabolome were assessed starting at 90 days of age. The LD but not UD of BPA resulted in individuals spending more time engaging in repetitive behaviors. GEN exposed individuals were more likely to exhibit such behaviors and showed socio-communicative disturbances. BPA and GEN exposed females had increased number of metabolites involved in carbohydrate metabolism and synthesis.. Males exposed to BPA or GEN showed alterations in lysine degradation and phenylalanine and tyrosine metabolism. Current findingsindicate cause for concern that developmental exposure to BPA or GEN might affect the microbiome-gut-brain axis.
Institute
University of Missouri
DepartmentMU Metabolomics Center
Last NameSarma
First NameSaurav
Address1201 Rollins street, 243 Bond Life Science Center, University of Missouri, Columbia, MO 65211, USA
Emailsarmas@missouri.edu
Phone3366713357
Submit Date2020-04-12
Num Groups8
Total Subjects78
Num Males37
Num Females41
Raw Data AvailableYes
Raw Data File Type(s)baf
Analysis Type DetailGC-MS/LC-MS
Release Date2020-05-13
Release Version1
Saurav Sarma Saurav Sarma
https://dx.doi.org/10.21228/M8710D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN002266 AN002267 AN002268
Analysis type MS MS MS
Chromatography type Reversed phase GC GC
Chromatography system Waters Acquity I-Class Agilent 6890N Agilent 6890N
Column Waters Acquity BEH C18 (150 x 2mm,1.7um) DB-5MS (J&W Scientific) 60m DB-5MS (J&W Scientific) 60m
MS Type ESI EI EI
MS instrument type QTOF Single quadrupole Single quadrupole
MS instrument name Bruker maXis Impact qTOF Agilent 5973 Agilent 5973
Ion Mode POSITIVE POSITIVE POSITIVE
Units intensity intensity intensity

Chromatography:

Chromatography ID:CH001665
Instrument Name:Waters Acquity I-Class
Column Name:Waters Acquity BEH C18 (150 x 2mm,1.7um)
Column Pressure:>11000 psi
Column Temperature:60
Flow Gradient:Solvent B (acetonitrile) was increased from 5% to 70% over 30 min, then to 95% over 3 min, held at 95% for 3 min, then returned to 5% for equilibrium
Flow Rate:0.560 ml/min
Internal Standard:Umbelliferon
Retention Time:1 to 35 min
Solvent A:100% water; 0.1% formic acid
Solvent B:100% acetonitrile
Analytical Time:40 min
Chromatography Type:Reversed phase
  
Chromatography ID:CH001666
Chromatography Summary:5:1 split for GCMS-polar injection with 1uL injection volume.
Instrument Name:Agilent 6890N
Column Name:DB-5MS (J&W Scientific) 60m
Column Pressure:variable
Column Temperature:variable between 80-315
Flow Rate:1mL/Min of Helium gas
Internal Standard:Ribitol
Retention Time:9 to 61 min
Sample Injection:5:1 split injection with 1uL injection volume
Analytical Time:61 min
Chromatography Type:GC
  
Chromatography ID:CH001667
Chromatography Summary:1:1 split for GCMS-nonpolar injection with 1uL injection volume.
Instrument Name:Agilent 6890N
Column Name:DB-5MS (J&W Scientific) 60m
Column Pressure:variable
Column Temperature:variable between 80-315
Flow Rate:1mL/Min of Helium gas
Internal Standard:Docosanol
Retention Time:9 to 61 min
Sample Injection:1:1 split injection with 1uL injection volume
Analytical Time:61 min
Chromatography Type:GC
  logo